First-line Therapy of untreated advanced or metastatic Renal Cell Cancer
   Randomized, open, Phase-3 Study of Nivolumab in Combination with
   Cabozantinib versus Sunitinib in Participants with previously untreated,
   advanced or metastatic Renal Cell Cancer

Title:: First-line Therapy of untreated advanced or metastatic Renal Cell Cancer Randomized, open, Phase-3 Study of Nivolumab in Combination with Cabozantinib versus Sunitinib in Participants with previously untreated, advanced or metastatic Renal Cell Cancer
Document type:: Editorial Material
Author(s):: Rexer, H.; Steiner, T.; Retz, M.
Journal title abbreviation:: Urologe A
Year:: 2018
Journal volume:: 57
Journal issue:: 12
Pages contribution:: 1532-1533
Fulltext / DOI:: doi:10.1007/s00120-018-0816-y
Print-ISSN:: 0340-2592
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: